News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
105,199 Results
Type
Article (4226)
Company Profile (22)
Press Release (100951)
Section
Business (31928)
Career Advice (107)
Deals (5247)
Drug Delivery (4)
Drug Development (5386)
Employer Resources (11)
FDA (3183)
Job Trends (2073)
News (46849)
Policy (3869)
Tag
Academia (362)
Africa (128)
Alliances (11079)
Alzheimer's disease (257)
Approvals (3184)
Arizona (37)
Artificial intelligence (20)
Asia (5245)
Australia (1205)
Bankruptcy (45)
Best Places to Work (1684)
Biotechnology (11)
Breast cancer (10)
C2C Services and Suppliers (25215)
California (234)
Canada (124)
Cancer (74)
Career advice (98)
China (14)
Clinical research (3990)
Collaboration (27)
Colorado (15)
Connecticut (10)
COVID-19 (468)
Data (28)
Diagnostics (5446)
Earnings (10106)
Employer resources (10)
Europe (14738)
Events (13076)
Executive appointments (23)
FDA (3215)
Florida (30)
Funding (28)
Georgia (16)
GLP-1 (36)
Government (620)
Healthcare (2877)
Hotbed/Location (71180)
Illinois (41)
Indiana (9)
Infectious disease (472)
Inflammatory bowel disease (11)
Interviews (12)
IPO (1761)
Japan (7)
Job creations (399)
Job search strategy (94)
Kansas (11)
Layoffs (21)
Legal (526)
Liver cancer (8)
Lung cancer (8)
Maine (19)
Manufacturing (13)
Maryland (31)
Massachusetts (121)
Medical device (2401)
Medtech (2401)
Mergers & acquisitions (3474)
Metabolic disorders (10)
Michigan (42)
Minnesota (56)
Multiple sclerosis (8)
Neuroscience (272)
New Hampshire (14)
New Jersey (49)
New Mexico (13)
New York (122)
NextGen Class of 2024 (701)
Non-profit (542)
North Carolina (137)
Northern California (121)
Ohio (10)
Opinion (9)
Pennsylvania (33)
People (8762)
Phase I (1212)
Phase II (1699)
Phase III (1518)
Pipeline (7)
Postmarket research (212)
Preclinical (581)
Press Release (11)
Rare diseases (9)
Real estate (855)
Regulatory (2886)
Reports (10)
Research institute (426)
Resumes & cover letters (15)
South America (152)
Southern California (89)
Startups (622)
Tennessee (8)
Texas (33)
United States (1166)
Utah (22)
Vaccines (23)
Virginia (10)
Washington State (26)
Date
Today (19)
Last 7 days (91)
Last 30 days (328)
Last 365 days (5502)
2024 (3861)
2023 (6127)
2022 (10208)
2021 (9618)
2020 (8992)
2019 (6146)
2018 (4851)
2017 (5400)
2016 (5389)
2015 (6109)
2014 (4629)
2013 (4126)
2012 (4434)
2011 (4628)
2010 (4078)
105,199 Results for "precipio diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders
Specialty diagnostics company Precipio, Inc., announced that the company’s 2024 Annual Meeting of Shareholders was convened and adjourned, without any business being conducted, due to lack of the required quorum.
June 13, 2024
·
7 min read
Pharm Country
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
Management of specialty cancer diagnostics company Precipio, Inc. is requesting that shareholders instruct their brokers to vote their shares immediately no later than 11pm Eastern Time.
June 12, 2024
·
3 min read
Press Releases
GenomOncology Partners with Precipio to Advance Myeloid Testing and Reporting
September 11, 2024
·
3 min read
Pharm Country
Precipio Announces Year end 2023 Shareholder Update Call
Specialty cancer diagnostics company Precipio, Inc., will be hosting its year end 2023 corporate update call on April 1st, 2024 at 5:00 PM ET.
March 25, 2024
·
3 min read
Press Releases
Precipio Announces Q2-2024 Shareholder Update Call
August 16, 2024
·
3 min read
Business
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the sales and distribution of its products into the Japanese market.
January 17, 2024
·
4 min read
Business
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
Specialty cancer diagnostics company Precipio, Inc. announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products.
February 6, 2024
·
3 min read
Business
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarterResults clearly demonstrate the business’s ability to reach breakeven in the near future
Specialty cancer diagnostics company Precipio, Inc. announces that continued revenue growth generated cash levels that bring the company closer to breakeven.
January 23, 2024
·
4 min read
Business
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
Specialty cancer diagnostics company Precipio, Inc., announces that for the full year of 2023, its unaudited revenues have grown from $9.4M in 2022 to $15.2M in 2023, an increase of 60% year over year.
February 13, 2024
·
3 min read
Business
Precipio Announces Christina Valauri joins the Board of DirectorsDouglas Fisher, MD will step down as Director, and remain as a board observer
Specialty cancer diagnostics company Precipio, Inc. is pleased to welcome Christina Valauri to its board of directors effective Jan 1st, 2024.
January 2, 2024
·
5 min read
1 of 10,520
Next
